10-Q 06-30-25 - IGC Pharma, INC.

SEC

Filings

August 14, 2025

10-Q 06-30-25

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-02-26

January 2, 2026

CEO Update

IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances

February 17, 2026

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

February 12, 2026